Raj Vaghela

Raj Vaghela, Founder and CEO of PubHive, shares insights from nearly 20 years in the biopharmaceutical industry. He discusses how AI can mitigate the burdens pharmacovigilance professionals face with the growing volume of data and adverse events. Raj highlights the role of AI in enhancing literature monitoring, safety reviews, and signal surveillance. He also explains how structured and unstructured data integration can streamline processes and improve drug safety compliance. Overall, it's a fascinating exploration of AI's transformative potential in pharma.